NCT06194422 is a clinical trial in Psychiatric Comorbidities, sponsored by Assiut University.

Who is sponsoring NCT06194422?

NCT06194422 is sponsored by Assiut University.

What condition does NCT06194422 study?

NCT06194422 studies Psychiatric Comorbidities.

Is NCT06194422 still recruiting?

NCT06194422 is currently status unknown. Last updated 8 January 2024.

Last reviewed 2024-01-08 · How we verify

NCT06194422

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Psychiatric Comorbidities in Children With Generalized Epilepsy

Status unknown Last updated 8 January 2024

What this trial tests

trial in Psychiatric Comorbidities in 62 participants. Status unknown.

Timeline

30 December 2023

Primary endpoint
31 December 2024

24 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	62
Start date	30 December 2023
Primary completion	31 December 2024
Estimated completion	24 March 2025

Conditions studied

Psychiatric Comorbidities — all drugs for Psychiatric Comorbidities →

Sponsor

Assiut University

Who can join

Adults 6 to 17, any sex, with Psychiatric Comorbidities. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Epilepsy is defined as a chronic disorder that presents with recurrent episodes of unprovoked seizures. Epileptic seizures are caused by excessive excitation of cortical neurons. The condition has various etiologies and comorbidities. Classification; The Classification of Epilepsies includes several diagnostic levels (steps): 1. from seizure type to epilepsy type (generalized/focal/combined generalized and focal/unknown) 2. etiology (genetic/ structural/ infectious/ metabolic/ immune/unknown). A clinician can use any level of the classification

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06194422 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 8 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06194422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing